Sedat KADANALI, Bünyamin BÖREKÇİ, Hülya AKSOY, Nurinnisa ÖZTÜRK

Correlation between Calprotectin and Oxidized LDL in Preeclampsia

Aim: To evaluate the relationship between serum calprotectin and oxidized low density lipoprotein (LDL) in preeclamptic patients. Additionally, we aimed to measure serum malondialdehyde (MDA) levels as an oxidative stress marker. Materials and Methods: Serum calprotectin, oxidized LDL, and MDA levels were measured in a cross-sectional study of 61 preeclamptic patients (39 severe preeclampsia and 22 mild preeclampsia cases) and 20 healthy pregnant subjects. Serum MDA concentration was measured with spectrophotometric methods, and oxidized LDL and calprotectin were measured via enzyme-linked immunoassay (ELISA). Results: Serum calprotectin (P < 0.0001 and P = 0.014) and MDA (P = 0.001 and P = 0.028) levels were significantly higher in the severe and mild preeclampsia groups than in the healthy control group. Serum oxidized LDL concentration was slightly higher, but not did reach a statistically significant level, in the severe preeclampsia group than in the healthy pregnant group (P = 0.2). There was a significant negative correlation between the levels of calprotectin and oxidized LDL (r = -0.34, P = 0.006) in the mild and severe preeclampsia groups. The correlation between calprotectin and MDA was not statistically significant (P = 0.08). Conclusions: The findings suggest that increased calprotectin is associated with preeclampsia. Further study is necessary in order to determine whether or not high calprotectin levels prevent oxidation of circulating LDL in preeclampsia cases.

Anahtar Kelimeler:

Calprotectin, oxidized LDL, preeclampsia

Correlation between Calprotectin and Oxidized LDL in Preeclampsia

Keywords:

Calprotectin, oxidized LDL, preeclampsia,

PDF

___

1. Sibai BM. Preeclampsia as a cause of preterm and late preterm (near-term) births. Semin Perinatol 2006; 30: 16-9.
2. Luppi P, Haluszczak C, Betters D, Richard CA, Trucco M, DeLoia JA. Monocytes are progressively activated in the circulation of pregnant women. J Leukoc Biol 2002; 72: 874-84.
3. Luppi P, Deloia JA. Monocytes of preeclamptic women spontaneously synthesize pro-inflammatory cytokines. Clin Immunol 2006; 118: 268-75.
4. Williams MA, Woelk GB, King IB, Jenkins L, Mahomed K. Plasma carotenoids, retinol, tocopherols and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean woman Am J Hypertens 2003; 16: 665-72.
5. Ware-Jauregui S, Sanchez SE, Zhang C, Laraburre G, King IB, Williams MA. Plasma lipid concentrations in pre-eclampsia and normotensive Peruvian women. Int J Gynecol Obstet 1999; 67: 147-55
6. Sagol S, Özkınay E, Özsener S. Impaired antioxidant activity in women with pre-eclampsia Int J Gynecol Obstet 1999; 64: 121- 7.
7. Kim YJ, Park H, Lee HY, Ahn YM, Ha EH, Suh SH et al. Paraoxonase gene polymorphism, serum lipid, and oxidized lowdensity lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007; 133: 47-52.
8. Uzun H, Benian A, Madazli R, Topçuo lu MA, Aydin S, Albayrak M. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 2005; 60: 195- 200.
9. Belo L, Santos-Silva A, Caslake M, Pereira-Leite L, Quintanilha A, Rebelo I. Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size. Atherosclerosis 2005; 183: 185-6.
10. Raijmakers MT, van Tits BJ, Hak-Lemmers HL, Roes EM, Steegers EA, Peters WH. Low plasma levels of oxidized low density lipoprotein in preeclampsia. Acta Obstet Gynecol Scand 2004; 83: 1173-7.
11. Paternoster DM, Fantinato S, Stella A, Nanhornguè KN, Milani M, Plebani M et al. C-reactive protein in hypertensive disorders in pregnancy. Clin Appl Thromb Hemost 2006; 12: 330-37.
12. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001; 32: 171-77.
13. Braekke K, Holthe MR, Harsem NK, Fagerhol MK, Staff AC. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia. Am J Obstet Gynecol 2005; 193: 227-33.
14. Holthe MR, Staff AC, Berge LN, Fagerhol MK, Lyberg T. Calprotectin plasma level is elevated in preeclampsia. Acta Obstet Gynecol Scand 2005; 84: 151-54.
15. ACOG technical bulletin. Hypertension in pregnancy. Number 219-January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1996; 53: 175-83.
16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxidase in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-58.
17. Sarandöl E, Safak O, Dirican M, Uncu G. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia. Clin Biochem 2004; 37: 990-96.
18. Kharb S. Total free radical trapping antioxidant potential in preeclampsia. Int J Gynaecol Obstet 2000; 69: 23-6.
19. Barden A, Graham D, Beilin LJ, Ritchie J, Baker R, Walters BN et al. Neutrophil CD11B expression and neutrophil activation in preeclampsia. Clin Sci (Lond) 1997; 92: 37-44.
20. Clark P, Boswell F, Greer IA The neutrophil and preeclampsia. Semin Reprod Endocrinol 1998; 16: 57-64.
21. Mellembakken JR. Activation of leukocyte during the uteroplacental passage in preeclampsia. Hypertension 2002; 39: 155-60.
22. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986; 320: 454-56.
23. Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993; 53: 197-204.
24. Kerkhoff C, Klempt M, Sorg C. Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1998; 1448: 200-11.
25. Hetland G, Talgo GJ, Fagerhol MK. Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro. Mol Pathol 1998; 51: 143-8.
26. Brun JG, Jonsson R, Haga HJ: Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol. 1994; 21: 733-8.
27. Lugering N, Stoll R, Schmid KW, Kucharzik T, Stein H, Burmeister G et al. The myeloic related protein MRP8/ 14 (27E10 antigen) usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest 1995; 25: 659-64.
28. Karlsson H, Leanderson P, Tagesson C, Lindahl M. Lipoproteomics I: mapping of proteins in low-density lipoprotein using twodimensional gel electrophoresis and mass spectrometry. Proteomics 2005; 5: 551-65.
29. Mol MJ, de Rijke YB, Demacker PN, Stalenhoef AF. Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis 1997; 129: 169-76.
30. Kummerow FA, Olinescu RM, Fleischer L, Handler B, Shinkareva SV. The relationship of oxidized lipids to coronary artery stenosis. Atherosclerosis 2000; 149: 181-90.